ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Nektar Therapeutics clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 39 studies whose lead sponsor is Nektar Therapeutics. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Nektar Therapeutics with Jiangsu HengRui Medicine and AbbVie →

Pipeline: 1 program

Each counted once: 1 with a study Nektar Therapeutics leads registered in the last two years.

  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Nektar Therapeutics’ own registered studies; Nektar Therapeutics’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Nektar Therapeutics’ studies test, most open studies first — 7 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

All 39 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now25%
  • Under way, not recruiting13%
  • Completed2769%
  • Stopped early923%Terminated 8 · Withdrawn 1

Phase

Where

  • United States39
  • United Kingdom9
  • Spain9
  • Belgium9
  • Canada8
  • Australia8

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14
  8. 15
  9. 16
  10. 17
  11. 18
  12. 619
  13. 20
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 226

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Nektar Therapeutics.

  • Nektar Therapeutics
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    39 studies

Studies

Recruiting first, then most recently updated. Showing 39 of 39.